These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33230463)

  • 1. TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.
    Ma HY; Li Y; Yin HZ; Yin H; Qu YY; Xu QY
    Mol Ther Nucleic Acids; 2020 Dec; 22():640-656. PubMed ID: 33230463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. circHUWE1 Exerts an Oncogenic Role in Inducing DDP-Resistant NSCLC Progression Depending on the Regulation of miR-34a-5p/TNFAIP8.
    Yang X; Sun Q; Song Y; Li W
    Int J Genomics; 2021; 2021():3997045. PubMed ID: 34901263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
    Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
    Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway.
    Li Y; Ma HY; Hu XW; Qu YY; Wen X; Zhang Y; Xu QY
    Cancer Cell Int; 2020; 20():200. PubMed ID: 32514245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.
    Shen X; Lei J; Du L
    Exp Ther Med; 2020 Jan; 19(1):375-383. PubMed ID: 31853314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer.
    Lv Y; Lv X; Yang H; Qi X; Wang X; Li C; Shang X; Guo H; Zhang J; Zhang Y
    Front Oncol; 2021; 11():678474. PubMed ID: 34026654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retraction Notice to: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression.
    Ma HY; Li Y; Yin HZ; Yin H; Qu YY; Xu QY
    Mol Ther Nucleic Acids; 2023 Dec; 34():102048. PubMed ID: 37829327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of METTL14-mediated m
    Gong S; Wang S; Shao M
    J Mol Med (Berl); 2022 Dec; 100(12):1771-1785. PubMed ID: 36352154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DLEU2 drives the malignant behaviors of thyroid cancer through mediating the miR-205-5p/TNFAIP8 axis.
    Yang J; Huang Y; Dong B; Dai Y
    Endocr Connect; 2021 Apr; 10(4):471-483. PubMed ID: 33764889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway.
    Li H; Yin H; Yan Y
    Int J Biol Markers; 2022 Jun; 37(2):178-190. PubMed ID: 35341378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptionally regulated miR-26a-5p may act as BRCAness in Triple-Negative Breast Cancer.
    Zhang Y; Lv L; Zheng R; Xie R; Yu Y; Liao H; Chen J; Zhang B
    Breast Cancer Res; 2023 Jun; 25(1):75. PubMed ID: 37365643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
    Nafea H; Youness RA; Abou-Aisha K; Gad MZ
    J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis.
    Wang L; Yang X; Zhou F; Sun X; Li S
    Bioengineered; 2022 Mar; 13(3):7197-7208. PubMed ID: 35263216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
    Wang Z; Wang X
    J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
    Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
    Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.